Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT06707493 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 75 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT06707493 is currently recruiting participants. This phase2 study for acute myeloid leukemia is actively seeking new participants at 7 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06707493 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06707493 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.